Sanisure Announces the Acquisition of MED
Sanisure, a leading company in the single-use bioprocessing technology field, has announced the acquisition of Medical Elastomer Development, Inc ("
MED") a silicone extrusion facility from Q Holding, a 3i portfolio company.
This high-tech facility located in Twinsburg, Ohio, serves industry-leading customers in the medical device and bioprocessing markets.
Sanisure has vertically integrated manufacturing and assembly facilities in both North America and Europe, and it provides a broad product portfolio to its clients on a global scale.
Sanisure offers solutions for critical fluid path technologies, including Mixed4Sure™ closed Carboy Mixing system, Cap2v8® solutions, PharmaTainer™ bottles & carboys, aSURE® fittings, Bio-Ease™ clamps, Gamma stable Stir Bars and an increased range of silicone extrusion and other elastomeric solutions such as the Cellgyn® TPE, TPFE, Kynar tubing, etc.
Steven Chevillotte, CEO of Sanisure, commented:
"We are excited to have the MED Twinsburg Team joining Sanisure's growing family. We continue to invest in critical technologies and capabilities that drive innovation and supply security for our global customer base.
State-of- the-art silicone extrusion capabilities are core to our portfolio of fluid management products and solutions and enable us to provide both high quality silicone tubing and vertically integrated bioprocessing single-use solutions to our customers."
3i Partner Richard Relyea made the following statement on the acquisition:
"We continue to support Sanisure's strategy through both organic and inorganic growth opportunities. This addition further strengthens Sanisure's offering to key customers working on the development and commercialization of monoclonal antibody, vaccine, and cell and gene therapy modalities with single-use technologies in a variety of upstream and downstream applications."
Source
